Balekudaru S, Choudhari N S, Rewri P, George R, Bhende P S, Bhende M, Lingam V, Lingam G
Jadhavbhai Nathamal Singhvi Department of Glaucoma, Medical Research Foundation, Sankara Nethralaya, Chennai, India.
VST Glaucoma Center, L. V. Prasad eye Institute, Kallam Anji Reddy Campus, Hyderabad, India.
Eye (Lond). 2017 Jun;31(6):947-955. doi: 10.1038/eye.2017.32. Epub 2017 Mar 3.
PurposeTo assess outcomes of surgical management of malignant glaucoma in terms of re-formation of anterior chamberMethodsThis was a retrospective analysis of consecutive patients who underwent surgical treatment for malignant glaucoma between January 1995 and December 2013 at a tertiary care ophthalmic institute, with a minimum follow up of 2 months.ResultsFifty eight eyes of 58 patients were included. Fifty two (89.7%) patients had primary angle closure glaucoma. The majority had undergone glaucoma filtration surgery earlier (n=53, 91.4%). Lensectomy and anterior vitrectomy was performed in 15 (25.9%) eyes (Group 1). Vitrectomy and anterior chamber re-formation was performed in 27 (46.6%) eyes (Group 2). Vitrectomy-phacoemulsification-vitrectomy was performed in 16 (27.6%) eyes (Group 3). Communication between the two segments of eye through anterior hyaloid, lens capsule complex and/or iris was achieved in all groups. The median follow-up (Inter-quartile range) was 30 (71.5) months. Anterior chamber re-formation was achieved in 56 (96.5%) eyes at final visit. The improvement in mean±SD LogMAR visual acuity (1.1±1 to 0.7±0.8) and reduction in number ±SD of anti-glaucoma medications (2.1±1.1 to 1±1.6) between onset and final visit were significant (P=0.02 and <0.01, respectively). The intraocular pressure (mm Hg) at onset and at final visit was 30.7±17.4 and 14±6.2, 32.8±12.6 and 15.3±7.4, and 27.2±14 and 10.9±3 in groups 1-3, respectively (all P<0.01).ConclusionOur anatomical success rate was high. The key element in achieving this outcome was the establishment of a patent communication between the vitreous cavity and the anterior chamber.
根据前房的重新形成情况评估恶性青光眼手术治疗的效果。
这是一项对1995年1月至2013年12月期间在一家三级眼科医疗机构接受恶性青光眼手术治疗的连续患者进行的回顾性分析,最短随访时间为2个月。
纳入了58例患者的58只眼。52例(89.7%)患者患有原发性闭角型青光眼。大多数患者此前接受过青光眼滤过手术(n = 53,91.4%)。15只眼(25.9%)行晶状体切除术和前部玻璃体切除术(第1组)。27只眼(46.6%)行玻璃体切除术和前房重建术(第2组)。16只眼(27.6%)行玻璃体切割-超声乳化-玻璃体切除术(第3组)。所有组均通过前部玻璃体、晶状体囊复合体和/或虹膜实现了眼内两段之间的沟通。中位随访时间(四分位间距)为30(71.5)个月。末次随访时56只眼(96.5%)实现了前房重建。发病时与末次随访时平均±标准差的LogMAR视力(从1.1±1改善至0.7±0.8)以及抗青光眼药物数量±标准差的减少(从2.1±1.1减少至1±1.6)均有显著差异(P值分别为0.02和<0.01)。第1 - 3组发病时和末次随访时的眼压(mmHg)分别为30.7±17.4和14±6.2、32.8±12.6和15.3±7.4、27.2±14和10.9±3(所有P<0.01)。
我们的解剖学成功率很高。实现这一结果的关键因素是在玻璃体腔和前房之间建立通畅的沟通。